Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)
Launched by KING'S COLLEGE LONDON · May 8, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The CArdiovascular Inflammation Registry (CAIR) is a clinical study looking at how inflammation affects various heart conditions, such as myocarditis (inflammation of the heart muscle), heart attacks, and heart failure. Researchers want to gather information from patients who have these acute cardiovascular diseases to better understand how inflammation plays a role in these conditions. By collecting data from many patients over time, they hope to discover new ways to treat and manage these heart issues, which can sometimes lead to serious complications.
If you or a family member is 13 years or older and has been admitted to the hospital for an acute heart condition, you may be eligible to participate in this study. While the trial is not yet recruiting participants, those who join can expect to provide information about their health and undergo routine evaluations, which will help researchers learn more about the link between inflammation and heart disease. This study is important because it aims to fill in gaps in our understanding of these conditions and could lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient 13 years of age or older with an acute cardiovascular condition requiring hospital admission is eligible.
- Exclusion Criteria:
- • \<13 years of age
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported